6-152294065-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_182961.4(SYNE1):​c.17745C>T​(p.His5915=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.187 in 1,613,740 control chromosomes in the GnomAD database, including 30,213 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2201 hom., cov: 32)
Exomes 𝑓: 0.19 ( 28012 hom. )

Consequence

SYNE1
NM_182961.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.284
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 6-152294065-G-A is Benign according to our data. Variant chr6-152294065-G-A is described in ClinVar as [Benign]. Clinvar id is 130414.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152294065-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.284 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.222 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.17745C>T p.His5915= synonymous_variant 94/146 ENST00000367255.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.17745C>T p.His5915= synonymous_variant 94/1461 NM_182961.4 P1Q8NF91-1

Frequencies

GnomAD3 genomes
AF:
0.150
AC:
22850
AN:
152016
Hom.:
2203
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0362
Gnomad AMI
AF:
0.292
Gnomad AMR
AF:
0.171
Gnomad ASJ
AF:
0.146
Gnomad EAS
AF:
0.186
Gnomad SAS
AF:
0.234
Gnomad FIN
AF:
0.233
Gnomad MID
AF:
0.184
Gnomad NFE
AF:
0.192
Gnomad OTH
AF:
0.138
GnomAD3 exomes
AF:
0.190
AC:
47774
AN:
251352
Hom.:
5009
AF XY:
0.192
AC XY:
26115
AN XY:
135854
show subpopulations
Gnomad AFR exome
AF:
0.0339
Gnomad AMR exome
AF:
0.220
Gnomad ASJ exome
AF:
0.141
Gnomad EAS exome
AF:
0.189
Gnomad SAS exome
AF:
0.217
Gnomad FIN exome
AF:
0.233
Gnomad NFE exome
AF:
0.193
Gnomad OTH exome
AF:
0.184
GnomAD4 exome
AF:
0.191
AC:
279614
AN:
1461606
Hom.:
28012
Cov.:
35
AF XY:
0.192
AC XY:
139472
AN XY:
727100
show subpopulations
Gnomad4 AFR exome
AF:
0.0296
Gnomad4 AMR exome
AF:
0.211
Gnomad4 ASJ exome
AF:
0.139
Gnomad4 EAS exome
AF:
0.182
Gnomad4 SAS exome
AF:
0.214
Gnomad4 FIN exome
AF:
0.235
Gnomad4 NFE exome
AF:
0.194
Gnomad4 OTH exome
AF:
0.175
GnomAD4 genome
AF:
0.150
AC:
22846
AN:
152134
Hom.:
2201
Cov.:
32
AF XY:
0.154
AC XY:
11480
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.0361
Gnomad4 AMR
AF:
0.171
Gnomad4 ASJ
AF:
0.146
Gnomad4 EAS
AF:
0.186
Gnomad4 SAS
AF:
0.233
Gnomad4 FIN
AF:
0.233
Gnomad4 NFE
AF:
0.192
Gnomad4 OTH
AF:
0.136
Alfa
AF:
0.168
Hom.:
2784
Bravo
AF:
0.140
Asia WGS
AF:
0.168
AC:
584
AN:
3478
EpiCase
AF:
0.186
EpiControl
AF:
0.184

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 05, 2017- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 29, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsNov 02, 2018- -
Autosomal recessive ataxia, Beauce type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.28
DANN
Benign
0.36

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12664753; hg19: chr6-152615200; COSMIC: COSV54924635; API